Prolonged B-cell depletion in MuSK myasthenia gravis following rituximab treatment.
Publication
, Journal Article
Yi, JS; Decroos, EC; Sanders, DB; Weinhold, KJ; Guptill, JT
Published in: Muscle Nerve
December 2013
Duke Scholars
Published In
Muscle Nerve
DOI
EISSN
1097-4598
Publication Date
December 2013
Volume
48
Issue
6
Start / End Page
992 / 993
Location
United States
Related Subject Headings
- Rituximab
- Neurology & Neurosurgery
- Myasthenia Gravis
- Middle Aged
- Immunologic Factors
- Immunologic Deficiency Syndromes
- Humans
- Female
- Fatty Acids, Monounsaturated
- Cell Count
Citation
APA
Chicago
ICMJE
MLA
NLM
Yi, J. S., Decroos, E. C., Sanders, D. B., Weinhold, K. J., & Guptill, J. T. (2013). Prolonged B-cell depletion in MuSK myasthenia gravis following rituximab treatment. Muscle Nerve, 48(6), 992–993. https://doi.org/10.1002/mus.24063
Yi, John S., Emily C. Decroos, Donald B. Sanders, Kent J. Weinhold, and Jeffrey T. Guptill. “Prolonged B-cell depletion in MuSK myasthenia gravis following rituximab treatment.” Muscle Nerve 48, no. 6 (December 2013): 992–93. https://doi.org/10.1002/mus.24063.
Yi JS, Decroos EC, Sanders DB, Weinhold KJ, Guptill JT. Prolonged B-cell depletion in MuSK myasthenia gravis following rituximab treatment. Muscle Nerve. 2013 Dec;48(6):992–3.
Yi, John S., et al. “Prolonged B-cell depletion in MuSK myasthenia gravis following rituximab treatment.” Muscle Nerve, vol. 48, no. 6, Dec. 2013, pp. 992–93. Pubmed, doi:10.1002/mus.24063.
Yi JS, Decroos EC, Sanders DB, Weinhold KJ, Guptill JT. Prolonged B-cell depletion in MuSK myasthenia gravis following rituximab treatment. Muscle Nerve. 2013 Dec;48(6):992–993.
Published In
Muscle Nerve
DOI
EISSN
1097-4598
Publication Date
December 2013
Volume
48
Issue
6
Start / End Page
992 / 993
Location
United States
Related Subject Headings
- Rituximab
- Neurology & Neurosurgery
- Myasthenia Gravis
- Middle Aged
- Immunologic Factors
- Immunologic Deficiency Syndromes
- Humans
- Female
- Fatty Acids, Monounsaturated
- Cell Count